Prevalence and risk factors for hepatitis C virus infection among adolescents in detention

Archives of Pediatrics and Adolescent Medicine

Volumn 159, Issue 11, 2005, Pages 1015-1018

  Bair, Rita M ^a,c   Baillargeon, Jacques G ^a   Kelly, Patricia J ^a,e   Lerand, Sarah J ^a,d   Williams, Janet F ^a   Lyerla, Rob ^b   Alter, Miriam J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; BEHAVIOR; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; COUNSELING; DETENTION; DRUG USE; FEMALE; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HISPANIC; HUMAN; IMMUNIZATION; INJECTION; JUVENILE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SAMPLE; SCHOOL CHILD; SCREENING; TATTOOING; UNITED STATES;

ADOLESCENT; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HUMANS; MALE; PREVALENCE; PRISONERS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TEXAS;

EID: 27744447710     PISSN: 10724710     EISSN: 10724710     Source Type: Journal    
DOI: 10.1001/archpedi.159.11.1015     Document Type: Article

References (32)

1. Alter MJ. Hepatitis C virus infection in the United States. J Hepatol. 1999;31(Suppl 1):88-91.
2. Verucchi G, Attard L, Boschi A. HCV infection in childhood: prevalence of specific antibodies in healthy populations and children at risk [abstract]. Presented at: Second International Symposium on HCV; November 8, 1991; Los Angeles, Calif.
3. Tanaka E, Kiyosawa K, Sodeyama T, et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg. 1992;46:460-464.
4. Jonas MM, Robertson LM, Middleman AB. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr. 1997;131:314-316.
5. Ruiz-Moreno M, Leal-Orozco A, Millan A. Hepatitis C virus infection in children. J Hepatol. 1999;31(Suppl 1):124-129.
6. Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003;117:43-48.
7. Murray KF, Richardson LP, Morishima C, Owens JW, Gretch DR. Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics. 2003;111:153-157.
8. Noell J, Rohde P, Ochs L, et al. Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population. Sex Transm Dis. 2001;28:4-10.
9. Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis. 2000;182:1588-1594.
10. Diaz T, Des J, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health. 2001;91:23-30.
11. Gershon RR, Karkashian CD, Vlahov D, et al. Compliance with universal precautions in correctional health care facilities. J Occup Environ Med. 1999;41:181-189.
12. Hessl SM. Police and corrections. Occup Med. 2001;16:39-49.
13. Khan A, Simard E, Wurtzel H. The prevalence, risk factors, and incidence of hepatitis B infection among inmates in a state correctional facility [abstract]. Presented at: 130th Annual Meeting of the American Public Health Association; November 9, 2002; Philadelphia, Pa.
14. Weber FT, Elfenbein DS, Richards NL, Davis AB, Thomas J. Early sexual activity of delinquent adolescents. J Adolesc Health Care. 1989;10:398-403.
15. Setzer JR, Smith DP. Comprehensive school-based services for pregnant and parenting adolescents in West Dallas, Texas. J Sch Health. 1992;62:97-102.
16. Weber FT, Gearing J, Davis A, Conlon M. Prepubertal initiation of sexual experiences and older first partner predict promiscuous sexual behavior of delinquent adolescent males: unrecognized child abuse? J Adolesc Health. 1992;13:600-605.
17. Oh MK, Cloud GA, Wallace LS, Reynolds J, Sturdevant M, Feinstein RA. Sexual behavior and sexually transmitted diseases among male adolescents in detention. Sex Transm Dis. 1994;21:127-132.
18. Kelly PJ, Bair RM, Baillargeon J, German V. Risk behaviors and the prevalence of Chlamydia in a juvenile detention facility. Clin Pediatr (Phila). 2000;39:521-527.
19. Braithwaite R, Hammett T, Mayberry R. Prison and AIDS: A Public Health Challenge. San Francisco, Calif: Jossey-Bass Publishers; 1996.
20. Baillargeon J, Black SA, Pulvino J, Dunn K. The disease profile of Texas prison inmates. Ann Epidemiol. 2000;10:74-80.
21. Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52(RR-1):1-36.
22. Balasekaran R, Bulterys M, Jamal MM, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol. 1999;94:1341-1346.
23. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection: clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine. 2001;80:134-151.
24. de Nishioka SA, Gyorkos TW, Joseph L, Collet JP, MacLean JD. Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study. Eur J Epidemiol. 2003;18:441-449.
25. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect. 2004;132:409-415.
26. Alter MJ, Gerety RJ, Smallwood LA, et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis. 1982;145:886-893.
27. Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA. 1989;262:1201-1205.
28. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.
29. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996;334:1691-1696.
30. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors: NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology. 2000;31:756-762.
31. Briggs ME, Baker C, Hall R, et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology. 2001;34:1200-1205.
32. Gunn RA, Murray PJ, Brennan CH, Callahan DB, Alter MJ, Margolis HS. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis. 2003;30:340-344.